SPHK1 and hemolytic-uremic syndrome: We already previously described mice in our HUS model to develop only weak thrombocytopenia that might be masked by hypovolemia and consecutive hemoconcentration [61,63], as was also observed in the SphK1−/− mice with experimental HUS in the present study.